Recombinant Human Interferon α2b for Injection

北京远策药业有限责任公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeS8s0TD
Approval Number: 国药准字S19990013
Generic Name: 注射用重组人干扰素α2b
Generic Name En: Recombinant Human Interferon α2b for Injection
Trade Name: 远策素
Drug Type: 生物制品
Dosage Form: 注射剂(冻干)
Strength: (1)100万IU/支(2)300万IU/支
Reg Date: 2020-07-15
Company Name: 北京远策药业有限责任公司
Production Company Name: 北京远策药业有限责任公司
Production Company Address: （生产地址）北京市北京经济技术开发区荣昌东街7号隆盛工业园9号厂房
Company Detail Path: /organization/bei-jing-yuan-ce-yao-ye-you-xian-ze-ren-gong-si
Production Company Detail Path: /organization/bei-jing-yuan-ce-yao-ye-you-xian-ze-ren-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 15, 2020

Approval ID

7LeaeS8s0TD

Type

生物制品